A Study of Volatile Organic Compounds in Patients with Obstructive Sleep Apnea

<b>Background</b>: Obstructive Sleep Apnea (OSA) is a prevalent sleep disorder characterized by intermittent upper airway obstruction, leading to significant health consequences. Traditional diagnostic methods, such as polysomnography, are time-consuming and resource-intensive. <b>...

Full description

Saved in:
Bibliographic Details
Main Authors: Chuan Hao Gui, Zhunan Jia, Zihao Xing, Fuchang Zhang, Fang Du, Alex Chengyao Tham, Ming Yann Lim, Yaw Khian Chong, Agnes Si Qi Chew, Khai Beng Chong
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Metabolites
Subjects:
Online Access:https://www.mdpi.com/2218-1989/15/1/42
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588026497204224
author Chuan Hao Gui
Zhunan Jia
Zihao Xing
Fuchang Zhang
Fang Du
Alex Chengyao Tham
Ming Yann Lim
Yaw Khian Chong
Agnes Si Qi Chew
Khai Beng Chong
author_facet Chuan Hao Gui
Zhunan Jia
Zihao Xing
Fuchang Zhang
Fang Du
Alex Chengyao Tham
Ming Yann Lim
Yaw Khian Chong
Agnes Si Qi Chew
Khai Beng Chong
author_sort Chuan Hao Gui
collection DOAJ
description <b>Background</b>: Obstructive Sleep Apnea (OSA) is a prevalent sleep disorder characterized by intermittent upper airway obstruction, leading to significant health consequences. Traditional diagnostic methods, such as polysomnography, are time-consuming and resource-intensive. <b>Objectives</b>: This study explores the potential of proton-transfer-reaction mass spectrometry (PTR-MS) in identifying volatile organic compound (VOC) biomarkers for the non-invasive detection of OSA. <b>Methods</b>: Breath samples from 89 participants, including 49 OSA patients and 40 controls, were analyzed using PTR-MS. Significance analysis was performed between OSA patients and controls to identify potential biomarkers for OSA. To as-sess the differences in VOC concentrations between OSA patients and control subjects, the Wilcoxon rank-sum test was employed. partial least squares discriminant analysis (PLS-DA) analysis and heatmap plot was conducted to visualize the differentiation between OSA patients and control subjects based on their VOC profiles.In order to further investigate the correlation between identified biomarkers and the severity of OSA measured by Apnea–Hypopnea Index (AHI), regression analysis was conducted between biomarkers and AHI Index. <b>Results</b>: The results identified specific VOCs, including m045 (acetaldehyde), m095.950, and m097.071, which showed significant differences between OSA patients and controls. Advanced statistical analyses, including PLS-DA and correlation mapping, highlighted the robustness of these biomarkers, with m045 (acetaldehyde) specifically emerging as a potential biomarker associated with the AHI Index. <b>Conclusions</b>: This study underscores the potential of VOCs as biomarkers for identifying patients with severe AHI levels. The analysis of VOCs using PTR-MS presents a rapid, non-invasive, and cost-effective method that could be seamlessly integrated into clinical practice, allowing clinicians to better stratify patients based on their need for polysomnography and prioritize those requiring earlier testing. Future studies are necessary to validate these findings in larger cohorts and to explore the integration of PTR-MS with other diagnostic modalities for improved accuracy and clinical utility.
format Article
id doaj-art-e0855d3cfb874694bfdbb3d2ddf76586
institution Kabale University
issn 2218-1989
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Metabolites
spelling doaj-art-e0855d3cfb874694bfdbb3d2ddf765862025-01-24T13:41:16ZengMDPI AGMetabolites2218-19892025-01-011514210.3390/metabo15010042A Study of Volatile Organic Compounds in Patients with Obstructive Sleep ApneaChuan Hao Gui0Zhunan Jia1Zihao Xing2Fuchang Zhang3Fang Du4Alex Chengyao Tham5Ming Yann Lim6Yaw Khian Chong7Agnes Si Qi Chew8Khai Beng Chong9Tan Tock Seng Hospital, 11 Jln Tan Tock Seng, Singapore 308433, SingaporeBreathonix Pte Ltd., Block 71 Ayer Rajah Crescent, #05-19/20/21, Singapore 139951, SingaporeBreathonix Pte Ltd., Block 71 Ayer Rajah Crescent, #05-19/20/21, Singapore 139951, SingaporeBreathonix Pte Ltd., Block 71 Ayer Rajah Crescent, #05-19/20/21, Singapore 139951, SingaporeBreathonix Pte Ltd., Block 71 Ayer Rajah Crescent, #05-19/20/21, Singapore 139951, SingaporeTan Tock Seng Hospital, 11 Jln Tan Tock Seng, Singapore 308433, SingaporeTan Tock Seng Hospital, 11 Jln Tan Tock Seng, Singapore 308433, SingaporeTan Tock Seng Hospital, 11 Jln Tan Tock Seng, Singapore 308433, SingaporeTan Tock Seng Hospital, 11 Jln Tan Tock Seng, Singapore 308433, SingaporeTan Tock Seng Hospital, 11 Jln Tan Tock Seng, Singapore 308433, Singapore<b>Background</b>: Obstructive Sleep Apnea (OSA) is a prevalent sleep disorder characterized by intermittent upper airway obstruction, leading to significant health consequences. Traditional diagnostic methods, such as polysomnography, are time-consuming and resource-intensive. <b>Objectives</b>: This study explores the potential of proton-transfer-reaction mass spectrometry (PTR-MS) in identifying volatile organic compound (VOC) biomarkers for the non-invasive detection of OSA. <b>Methods</b>: Breath samples from 89 participants, including 49 OSA patients and 40 controls, were analyzed using PTR-MS. Significance analysis was performed between OSA patients and controls to identify potential biomarkers for OSA. To as-sess the differences in VOC concentrations between OSA patients and control subjects, the Wilcoxon rank-sum test was employed. partial least squares discriminant analysis (PLS-DA) analysis and heatmap plot was conducted to visualize the differentiation between OSA patients and control subjects based on their VOC profiles.In order to further investigate the correlation between identified biomarkers and the severity of OSA measured by Apnea–Hypopnea Index (AHI), regression analysis was conducted between biomarkers and AHI Index. <b>Results</b>: The results identified specific VOCs, including m045 (acetaldehyde), m095.950, and m097.071, which showed significant differences between OSA patients and controls. Advanced statistical analyses, including PLS-DA and correlation mapping, highlighted the robustness of these biomarkers, with m045 (acetaldehyde) specifically emerging as a potential biomarker associated with the AHI Index. <b>Conclusions</b>: This study underscores the potential of VOCs as biomarkers for identifying patients with severe AHI levels. The analysis of VOCs using PTR-MS presents a rapid, non-invasive, and cost-effective method that could be seamlessly integrated into clinical practice, allowing clinicians to better stratify patients based on their need for polysomnography and prioritize those requiring earlier testing. Future studies are necessary to validate these findings in larger cohorts and to explore the integration of PTR-MS with other diagnostic modalities for improved accuracy and clinical utility.https://www.mdpi.com/2218-1989/15/1/42clinical diagnosticsPTR-MSbreath analysisobstructive sleep apneabiomarkers
spellingShingle Chuan Hao Gui
Zhunan Jia
Zihao Xing
Fuchang Zhang
Fang Du
Alex Chengyao Tham
Ming Yann Lim
Yaw Khian Chong
Agnes Si Qi Chew
Khai Beng Chong
A Study of Volatile Organic Compounds in Patients with Obstructive Sleep Apnea
Metabolites
clinical diagnostics
PTR-MS
breath analysis
obstructive sleep apnea
biomarkers
title A Study of Volatile Organic Compounds in Patients with Obstructive Sleep Apnea
title_full A Study of Volatile Organic Compounds in Patients with Obstructive Sleep Apnea
title_fullStr A Study of Volatile Organic Compounds in Patients with Obstructive Sleep Apnea
title_full_unstemmed A Study of Volatile Organic Compounds in Patients with Obstructive Sleep Apnea
title_short A Study of Volatile Organic Compounds in Patients with Obstructive Sleep Apnea
title_sort study of volatile organic compounds in patients with obstructive sleep apnea
topic clinical diagnostics
PTR-MS
breath analysis
obstructive sleep apnea
biomarkers
url https://www.mdpi.com/2218-1989/15/1/42
work_keys_str_mv AT chuanhaogui astudyofvolatileorganiccompoundsinpatientswithobstructivesleepapnea
AT zhunanjia astudyofvolatileorganiccompoundsinpatientswithobstructivesleepapnea
AT zihaoxing astudyofvolatileorganiccompoundsinpatientswithobstructivesleepapnea
AT fuchangzhang astudyofvolatileorganiccompoundsinpatientswithobstructivesleepapnea
AT fangdu astudyofvolatileorganiccompoundsinpatientswithobstructivesleepapnea
AT alexchengyaotham astudyofvolatileorganiccompoundsinpatientswithobstructivesleepapnea
AT mingyannlim astudyofvolatileorganiccompoundsinpatientswithobstructivesleepapnea
AT yawkhianchong astudyofvolatileorganiccompoundsinpatientswithobstructivesleepapnea
AT agnessiqichew astudyofvolatileorganiccompoundsinpatientswithobstructivesleepapnea
AT khaibengchong astudyofvolatileorganiccompoundsinpatientswithobstructivesleepapnea
AT chuanhaogui studyofvolatileorganiccompoundsinpatientswithobstructivesleepapnea
AT zhunanjia studyofvolatileorganiccompoundsinpatientswithobstructivesleepapnea
AT zihaoxing studyofvolatileorganiccompoundsinpatientswithobstructivesleepapnea
AT fuchangzhang studyofvolatileorganiccompoundsinpatientswithobstructivesleepapnea
AT fangdu studyofvolatileorganiccompoundsinpatientswithobstructivesleepapnea
AT alexchengyaotham studyofvolatileorganiccompoundsinpatientswithobstructivesleepapnea
AT mingyannlim studyofvolatileorganiccompoundsinpatientswithobstructivesleepapnea
AT yawkhianchong studyofvolatileorganiccompoundsinpatientswithobstructivesleepapnea
AT agnessiqichew studyofvolatileorganiccompoundsinpatientswithobstructivesleepapnea
AT khaibengchong studyofvolatileorganiccompoundsinpatientswithobstructivesleepapnea